271 related articles for article (PubMed ID: 38673891)
21. Ovarian cancer in endometriosis: clinical and molecular aspects.
Lyttle B; Bernardi L; Pavone ME
Minerva Ginecol; 2014 Apr; 66(2):155-64. PubMed ID: 24848074
[TBL] [Abstract][Full Text] [Related]
22. Cancer Implications for Patients with Endometriosis.
Wilbur MA; Shih IM; Segars JH; Fader AN
Semin Reprod Med; 2017 Jan; 35(1):110-116. PubMed ID: 28049216
[TBL] [Abstract][Full Text] [Related]
23. The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer.
Banz C; Ungethuem U; Kuban RJ; Diedrich K; Lengyel E; Hornung D
Fertil Steril; 2010 Sep; 94(4):1212-1217. PubMed ID: 19643405
[TBL] [Abstract][Full Text] [Related]
24. Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis.
Driva TS; Schatz C; Haybaeck J
Biomolecules; 2023 Aug; 13(8):. PubMed ID: 37627318
[TBL] [Abstract][Full Text] [Related]
25. Involvement of pelvic inflammation-related mismatch repair abnormalities and microsatellite instability in the malignant transformation of ovarian endometriosis.
Fuseya C; Horiuchi A; Hayashi A; Suzuki A; Miyamoto T; Hayashi T; Shiozawa T
Hum Pathol; 2012 Nov; 43(11):1964-72. PubMed ID: 22626277
[TBL] [Abstract][Full Text] [Related]
26. The Evolution of Estrogen Receptor Signaling in the Progression of Endometriosis to Endometriosis-Associated Ovarian Cancer.
Andersen CL; Boisen MM; Sikora MJ; Ma T; Tseng G; Suryawanshi S; Vlad A; Elishaev E; Edwards RP; Oesterreich S
Horm Cancer; 2018 Dec; 9(6):399-407. PubMed ID: 30302736
[TBL] [Abstract][Full Text] [Related]
27. Discovering the Deregulated Molecular Functions Involved in Malignant Transformation of Endometriosis to Endometriosis-Associated Ovarian Carcinoma Using a Data-Driven, Function-Based Analysis.
Chang CM; Yang YP; Chuang JH; Chuang CM; Lin TW; Wang PH; Yu MH; Chang CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113136
[TBL] [Abstract][Full Text] [Related]
28. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
Erzen M; Rakar S; Klancnik B; Syrjänen K
Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420
[TBL] [Abstract][Full Text] [Related]
29. Endometriosis-associated ovarian cancer: What have we learned so far?
Herreros-Villanueva M; Chen CC; Tsai EM; Er TK
Clin Chim Acta; 2019 Jun; 493():63-72. PubMed ID: 30776361
[TBL] [Abstract][Full Text] [Related]
30. Differences in LINE-1 methylation between endometriotic ovarian cyst and endometriosis-associated ovarian cancer.
Senthong A; Kitkumthorn N; Rattanatanyong P; Khemapech N; Triratanachart S; Mutirangura A
Int J Gynecol Cancer; 2014 Jan; 24(1):36-42. PubMed ID: 24304685
[TBL] [Abstract][Full Text] [Related]
31. Histologic Subtypes in Endometriosis-Associated Ovarian Cancer and Ovarian Cancer Arising in Endometriosis: A Systematic Review and Meta-Analysis.
Chiaffarino F; Cipriani S; Ricci E; Esposito G; Parazzini F; Vercellini P
Reprod Sci; 2024 Jun; 31(6):1642-1650. PubMed ID: 38438776
[TBL] [Abstract][Full Text] [Related]
32. Endometriosis-associated Ovarian Cancers.
Anglesio MS; Yong PJ
Clin Obstet Gynecol; 2017 Dec; 60(4):711-727. PubMed ID: 28990985
[TBL] [Abstract][Full Text] [Related]
33. Distinct molecular pathways in ovarian endometrioid adenocarcinoma with concurrent endometriosis.
Zhang C; Wang X; Anaya Y; Parodi L; Cheng L; Anderson ML; Hawkins SM
Int J Cancer; 2018 Nov; 143(10):2505-2515. PubMed ID: 30152524
[TBL] [Abstract][Full Text] [Related]
34. Endometrial cancer with concomitant endometriosis is highly associated with ovarian endometrioid carcinoma: a retrospective cohort study.
Ishizaka A; Taguchi A; Tsuruga T; Maruyama M; Kawata A; Miyamoto Y; Tanikawa M; Ikemura M; Sone K; Mori M; Koga K; Ushiku T; Oda K; Osuga Y
BMC Womens Health; 2022 Aug; 22(1):332. PubMed ID: 35932070
[TBL] [Abstract][Full Text] [Related]
35. Cellular, histologic, and molecular changes associated with endometriosis and ovarian cancer.
Siufi Neto J; Kho RM; Siufi DF; Baracat EC; Anderson KS; Abrão MS
J Minim Invasive Gynecol; 2014; 21(1):55-63. PubMed ID: 23962574
[TBL] [Abstract][Full Text] [Related]
36. [Risk factors of endometriosis associated ovarian carcinoma in women aged 45 years and older].
He ZX; Wang S; Li ZF; Zhu L; Leng JH; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):314-319. PubMed ID: 28545269
[No Abstract] [Full Text] [Related]
37. Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype.
Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Konishi I
Cancer Lett; 2011 Nov; 310(2):129-33. PubMed ID: 21802200
[TBL] [Abstract][Full Text] [Related]
38. The relationship of endometriosis and ovarian malignancy: a review.
Nezhat F; Datta MS; Hanson V; Pejovic T; Nezhat C; Nezhat C
Fertil Steril; 2008 Nov; 90(5):1559-70. PubMed ID: 18993168
[TBL] [Abstract][Full Text] [Related]
39. Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics.
Li Q; Sun Y; Zhang X; Wang L; Wu W; Wu M; Meng C; Liu G
Cancer Biol Ther; 2019; 20(7):1029-1034. PubMed ID: 30913953
[No Abstract] [Full Text] [Related]
40. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.
Chene G; Ouellet V; Rahimi K; Barres V; Provencher D; Mes-Masson AM
Int J Gynaecol Obstet; 2015 Jul; 130(1):27-30. PubMed ID: 25912412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]